Butac, Thalia Mae S.
HRN: 25-13-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
11/20/2025
11/27/2025
PO
2.3mL
Q12h
PCAP
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines